Discover a study, involving over 13,000 patients with MASLD, that compared mortality rates and causes of death. Learn more.

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...

Discover a study that has proposed a predictive model for cirrhosis and hepatocellular carcinoma in individuals with ...

In the study population of more than 30,000 people without known liver disease, the proportion of persons with a liver ...

Chugai Pharma announces positive results from phase III TALENTACE study of Tecentriq & Avastin for unresectable hepatocellular carcinoma: Tokyo Thursday, May 22, 2025, 09:00 Hrs [ ...

Hepatocellular carcinoma (HCC), which accounts for up to 80% of cases of primary liver cancer, is typically diagnosed in an advanced stage, meaning a poor prognosis. Understanding what drives ...

Tumor burden score predicted survival in patients with a performance status of 0; only a high TBS predicted survival with a PS of 1 or 2.

According to studies, drinking the tea daily can decrease your risk of developing certain cancers, like liver cancer.